UF Health- Shands Hospital

Gainesville, Florida 32669

7 studies enrolling now · 43 studies all time

What they study most

Acute Kidney Injury, Anemia, Sickle Cell, Aneurysm of Aorta, Thoracic, Aneurysmal Disease, Angiotensin Converting Enzyme Inhibitor Induced Angioedema, Aorta, Thoracic Pathologies, Aortic Aneurysm, Aortic Aneurysm and Dissection, Aortic Diseases, Brain Injuries, Traumatic, Breast Neoplasms, COVID-19

Studies at this site

• MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study — Recruiting now
• A Study to Evaluate the Safety and Effectiveness of the Rapidlink Device When Used in Patients Undergoing an Open Surgical Procedure to Repair the Aorta — Recruiting now
• Strategy for Improving Stroke Treatment Response — Recruiting now
• Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2 — Recruiting now
• OPTIMUS PRIME: Safety and Feasibility of OPTune GIO® Integrated With MRI-gUided Laser Ablation Surgery and Pembrolizumab for Recurrent GlIoblastoMa, A randomizEd Trial — Recruiting now
• Stent Omission After Ureteroscopy and Lithotripsy in the Michigan Urological Surgery Improvement Collaborative — Recruiting now
• Fontan Udenafil Exercise Longitudinal Assessment Trial - 2 — Recruiting now
• Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis — Running, not enrolling
• Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors — Running, not enrolling
• Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients — Completed
• Fundamental Intelligent Building Blocks of the Intensive Care Unit (ICU) of the Future: Intelligent ICU of the Future — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of Taldefgrobep Alfa in Participants With Spinal Muscular Atrophy — Running, not enrolling
• Brain Oxygen Optimization in Severe TBI, Phase 3 — Running, not enrolling
• Prospective Multi-Center Randomized Study for Evaluating the EVAHEART®2 Left Ventricular Assist System — Paused
• A Long-term Study of ADYNOVI/ADYNOVATE in Participants With Haemophilia A — Running, not enrolling
• A Study to Learn About the Study Medicine (Elranatamab) in Participants With Multiple Myeloma That Has Come Back After Responding to Treatment or Has Not Responded to Treatment — Completed
• Sleep for Stroke Management and Recovery Trial — Running, not enrolling
• Blinded Efficacy and Safety Study of CAL02 IV Plus SOC in Subjects With Severe Community-Acquired Bacterial Pneumonia — Running, not enrolling
• Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial — Running, not enrolling
• ALTERRA Post-Approval Study — Running, not enrolling
• Study of Fordadistrogene Movaparvovec in Early Stage Duchenne Muscular Dystrophy — Stopped early
• Expanded Access for ATB200/AT2221 for the Treatment of IOPD — Available (expanded access)
• PICS: Subtitle Cardiac Dysfunction in Older Sepsis Survivors — Running, not enrolling
• Blood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects With GlioBlastoma Brain Tumors — Completed
• Broad-spectrum Rapid Antidote: Varespladib IV to Oral Trial for Snakebite (BRAVIO) — Completed
• Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease — Completed
• Study of Obeldesivir in Children and Adolescents With COVID-19 — Stopped early
• Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors — Running, not enrolling
• Apixaban for the Acute Treatment of Venous Thromboembolism in Children — Completed
• A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (PAH) — Completed
• Study of Durvalumab and Tremelimumab After Radiation for Microsatellite Stable Metastatic Colorectal Cancer Progressing on Chemotherapy — Completed
• Neurophysiologic Signatures of Trigeminal Neuralgia Pain — Completed
• Study of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized Patients — Completed
• Convalescent Plasma in Outpatients With COVID-19 — Completed
• Phase 3 Study of Reltecimod vs Placebo in Patients With Sepsis-associated Acute Kidney Injury — Stopped early
• Phase III Efficacy and Safety Study of AB103 in the Treatment of Patients With Necrotizing Soft Tissue Infections — Completed
• Blinded Safety & Efficacy Placebo Controlled Study of Icatibant for Angiotensin Converting Enzyme Inhibitor Induced Angioedema — Completed
• Autologous Stem Cell Transplantation for Patients With Recurrent Nasopharyngeal Carcinoma — Stopped early
• A Study Of Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive High-Dose Chemotherapy — Stopped early
• Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial — Stopped early
• Phase I, Dose Escalation Study of Decitabine — Completed
• Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study — Completed
• Mobile Health (mHealth) Black Women With Breast Cancer — Completed